Top compounds associated with response to RNF165


Feature Type Standardized
Nominal ANOVA
mRNA CR-1-31B CTRPv2 pan-cancer AAC 0.044 0.2
mRNA SB-743921 CTRPv2 pan-cancer AAC 0.046 0.2
mRNA AZ628 GDSC1000 pan-cancer AAC -0.063 0.2
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.056 0.2
mRNA Nilotinib GDSC1000 pan-cancer AAC 0.045 0.2
mRNA Doxorubicin gCSI pan-cancer AAC -0.065 0.2
mRNA selumetinib:JQ-1 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.05 0.2
mRNA XL-184 GDSC1000 pan-cancer AAC 0.041 0.2
mRNA BRD9876 CTRPv2 pan-cancer AAC -0.052 0.2
mRNA pac-1 GDSC1000 pan-cancer AAC -0.043 0.2
Download CSV